Tyra Biosciences Inc. (TYRA)
undefined
undefined%
At close: undefined
16.20
0.97%
Pre-market Jan 07, 2025, 05:24 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -69.13M -55.33M -26.29M -9.34M -4.07M
Depreciation & Amortization 353.00K 296.00K 140.00K 47.00K 8.00K
Stock-Based Compensation 13.53M 10.59M 2.89M 439.00K n/a
Other Working Capital -3.01M -8.20M -1.97M 51.00K 44.00K
Other Non-Cash Items -1.24M 3.00K 3.00K 15.00K 934.00K
Deferred Income Tax n/a n/a n/a 2.00K n/a
Change in Working Capital 6.36M -5.85M -481.00K 1.07M 505.00K
Operating Cash Flow -50.14M -50.28M -23.75M -7.76M -2.62M
Capital Expenditures -770.00K -559.00K -661.00K -312.00K -20.00K
Acquisitions n/a n/a 16.00K n/a n/a
Purchase of Investments -143.84M n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a 16.00 n/a n/a
Investing Cash Flow -144.60M -559.00K -645.00K -312.00K -20.00K
Debt Repayment n/a n/a -9.00K -17.00K -8.00K
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 1.54M 632.00K 130.14M 23.45M 165.00K
Financial Cash Flow 1.54M 632.00 311.35M 23.43M 157.00K
Net Cash Flow -193.21M -50.21M 286.96M 15.36M -2.48M
Free Cash Flow -50.91M -50.84M -24.41M -8.07M -2.64M